Boston Scientific highlights positive results of heart devices

|About: Boston Scientific Corpora... (BSX)|By:, SA News Editor

Boston Scientific (BSX) has reported favorable results in almost a dozen studies that tested the company's cardiac resynchronization therapy (CRT) defibrillators, platinum chromium stent platforms, and transcatheter aortic valve replacement.

Boston Scientific presented the data at the American College of Cardiology's Annual Scientific Session.

In a long-term study of patients with mild heart failure, there was a 41% relative reduction in the risk of death in those who received a Boston Scientific defibrillator with CRT compared with patients who received just a defibrillator. (PR)